Apyx Capital Stock from 2010 to 2025

APYX Stock

USD 1.42 0.01 0.70%

Apyx Medical Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to about 37.8 K in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

40.2 K

Current Value

37.8 K

Quarterly Volatility

1.8 K

Credit Downgrade

Yuan Drop

Covid

Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 736.2 K, Interest Expense of 3 M or Selling General Administrative of 59 M, as well as many indicators such as Price To Sales Ratio of 1.89, Dividend Yield of 0.0 or PTB Ratio of 3.71. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.

Check out the analysis of Apyx Medical Correlation against competitors.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Latest Apyx Medical's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Apyx Medical over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Apyx Medical's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Apyx Capital Stock Regression Statistics

	Arithmetic Mean	34,751
	Geometric Mean	34,712
	Coefficient Of Variation	5.05
	Mean Deviation	1,127
	Median	34,000
	Standard Deviation	1,755
	Sample Variance	3.1M
	Range	6.2K
	R-Value	0.63
	Mean Square Error	2M
	R-Squared	0.40
	Significance	0.01
	Slope	231.99
	Total Sum of Squares	46.2M

Apyx Capital Stock History

	2025	37.8 K
	2024	40.2 K
	2022	35 K

Other Fundumenentals of Apyx Medical

Issuance Of Capital Stock

Apyx Medical Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.71	0.05	-0.48	-0.01	0.74	0.71	-0.44	0.62	1.0	0.52	-0.74	-0.04	0.32	0.71	0.82	-0.59	0.74	-0.7	-0.88	0.88	0.95	0.53
Total Stockholder Equity	0.71		0.43	-0.76	0.61	0.22	0.41	-0.3	-0.11	0.72	0.67	-0.54	0.05	0.24	0.28	0.95	-0.55	0.46	-0.56	-0.71	0.87	0.77	-0.09
Current Deferred Revenue	0.05	0.43		-0.52	0.4	-0.12	-0.09	-0.24	-0.41	0.07	0.18	0.08	-0.06	0.15	-0.18	0.26	0.12	0.05	0.01	0.01	0.21	0.07	-0.45
Net Debt	-0.48	-0.76	-0.52		-0.48	-0.22	-0.4	0.18	0.17	-0.5	-0.6	0.46	-0.14	-0.16	-0.42	-0.71	0.37	-0.36	0.42	0.55	-0.63	-0.52	0.21
Retained Earnings	-0.01	0.61	0.4	-0.48		-0.57	-0.36	0.09	-0.7	0.01	0.26	0.06	0.04	-0.13	-0.43	0.49	-0.04	-0.38	0.04	0.02	0.35	0.15	-0.58
Accounts Payable	0.74	0.22	-0.12	-0.22	-0.57		0.83	-0.34	0.8	0.74	0.33	-0.68	0.05	0.24	0.88	0.37	-0.44	0.82	-0.6	-0.74	0.45	0.61	0.7
Net Receivables	0.71	0.41	-0.09	-0.4	-0.36	0.83		-0.31	0.55	0.71	0.61	-0.75	0.11	0.27	0.89	0.51	-0.58	0.84	-0.68	-0.83	0.52	0.61	0.48
Good Will	-0.44	-0.3	-0.24	0.18	0.09	-0.34	-0.31		-0.27	-0.38	-0.24	-0.12	0.77	-0.72	-0.31	-0.17	0.05	-0.19	0.13	0.17	-0.17	-0.2	-0.06
Total Liab	0.62	-0.11	-0.41	0.17	-0.7	0.8	0.55	-0.27		0.6	-0.01	-0.45	-0.1	0.21	0.69	0.09	-0.21	0.55	-0.38	-0.47	0.28	0.5	0.85
Total Current Assets	1.0	0.72	0.07	-0.5	0.01	0.74	0.71	-0.38	0.6		0.53	-0.78	0.04	0.25	0.7	0.84	-0.61	0.75	-0.71	-0.89	0.9	0.97	0.51
Short Term Debt	0.52	0.67	0.18	-0.6	0.26	0.33	0.61	-0.24	-0.01	0.53		-0.51	0.07	0.25	0.48	0.65	-0.49	0.48	-0.54	-0.66	0.61	0.54	-0.03
Intangible Assets	-0.74	-0.54	0.08	0.46	0.06	-0.68	-0.75	-0.12	-0.45	-0.78	-0.51		-0.58	0.24	-0.7	-0.74	0.64	-0.73	0.72	0.88	-0.77	-0.81	-0.4
Common Stock	-0.04	0.05	-0.06	-0.14	0.04	0.05	0.11	0.77	-0.1	0.04	0.07	-0.58		-0.81	0.01	0.24	-0.39	0.21	-0.2	-0.22	0.2	0.17	-0.03
Property Plant Equipment	0.32	0.24	0.15	-0.16	-0.13	0.24	0.27	-0.72	0.21	0.25	0.25	0.24	-0.81		0.31	0.06	0.04	0.32	-0.18	-0.21	0.1	0.13	0.19
Long Term Debt	0.71	0.28	-0.18	-0.42	-0.43	0.88	0.89	-0.31	0.69	0.7	0.48	-0.7	0.01	0.31		0.4	-0.36	0.74	-0.63	-0.78	0.49	0.6	0.57
Net Tangible Assets	0.82	0.95	0.26	-0.71	0.49	0.37	0.51	-0.17	0.09	0.84	0.65	-0.74	0.24	0.06	0.4		-0.67	0.55	-0.65	-0.82	0.95	0.89	0.1
Long Term Debt Total	-0.59	-0.55	0.12	0.37	-0.04	-0.44	-0.58	0.05	-0.21	-0.61	-0.49	0.64	-0.39	0.04	-0.36	-0.67		-0.63	0.52	0.63	-0.55	-0.58	-0.28
Capital Surpluse	0.74	0.46	0.05	-0.36	-0.38	0.82	0.84	-0.19	0.55	0.75	0.48	-0.73	0.21	0.32	0.74	0.55	-0.63		-0.71	-0.85	0.6	0.68	0.54
Deferred Long Term Liab	-0.7	-0.56	0.01	0.42	0.04	-0.6	-0.68	0.13	-0.38	-0.71	-0.54	0.72	-0.2	-0.18	-0.63	-0.65	0.52	-0.71		0.82	-0.71	-0.73	-0.35
Short Long Term Debt	-0.88	-0.71	0.01	0.55	0.02	-0.74	-0.83	0.17	-0.47	-0.89	-0.66	0.88	-0.22	-0.21	-0.78	-0.82	0.63	-0.85	0.82		-0.87	-0.9	-0.42
Net Invested Capital	0.88	0.87	0.21	-0.63	0.35	0.45	0.52	-0.17	0.28	0.9	0.61	-0.77	0.2	0.1	0.49	0.95	-0.55	0.6	-0.71	-0.87		0.96	0.19
Net Working Capital	0.95	0.77	0.07	-0.52	0.15	0.61	0.61	-0.2	0.5	0.97	0.54	-0.81	0.17	0.13	0.6	0.89	-0.58	0.68	-0.73	-0.9	0.96		0.43
Capital Stock	0.53	-0.09	-0.45	0.21	-0.58	0.7	0.48	-0.06	0.85	0.51	-0.03	-0.4	-0.03	0.19	0.57	0.1	-0.28	0.54	-0.35	-0.42	0.19	0.43

Click cells to compare fundamentals

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Capital Stock	40.2 K	37.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Apyx Capital Stock from 2010 to 2025

Latest Apyx Medical's Capital Stock Growth Pattern

Apyx Capital Stock Regression Statistics

Apyx Capital Stock History

Other Fundumenentals of Apyx Medical

Apyx Medical Capital Stock component correlations

About Apyx Medical Financial Statements

Also Currently Popular

Additional Tools for Apyx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY